Page 134 - Prostate News Today

Researchers develop a new method for the detection and evolution of kidney cancer The research groups Mintota and Photochemistry Reactivity Group of the faculties of Chemistry and Pharmacy of the University of Valencia have developed a method for the detection and evolution of kidney cancer through urine and the dispersion of gold nanoparticles, in what is the first system that will provide reliable information on the existence and progress of this pathology. The patent has been registered by t...

Suspected heart attack? Don’t fear the emergency room due to COVID-19 In addition to a prompt assessment and potentially lifesaving treatment, expect a COVID-19 test and extra safety precautions. Published: May, 2021 Even before the pandemic, people with heart attack symptoms sometimes hesitated to seek emergency care. But during the first wave of COVID-19 infections in early 2020, many more people than usual stayed away. From mid-March to late May 2020, emergency room visits for heart attack...

(0) BRUSSELS, Belgium and MELBOURNE, Australia, April 20, 2021 (GLOBE NEWSWIRE) -- The Oncidium Foundation, a non-profit organisation created to promote and support the development of radiopharmaceuticals for better patient access, and Telix Pharmaceuticals Limited (Telix), a radiopharmaceutical company developing diagnostic and therapeutic products (theranostics) using Molecularly Targeted Radiation (MTR), are pleased to announce the launch of the NOBLE Registry, an international clinical coll...

Beloved News Center Maine Anchor Lee Goldberg Has Prostate Cancer Maine Loves Lee Lee Goldberg has been a News Center Maine staple for decades. From the sports desk to the Morning Report Mainers rely on Lee for the hard news and a few laughs. Lee has always been open about his personal life. Typically, were hearing joyful news of another Goldberg baby. This weekend, however, we learned that Lee has been diagnosed with prostate cancer. PSA About PSA Lee made the announcement on Facebook about hi...

Richard Martin, Professor of Clinical Epidemiology Cancer Research UK A leading cancer scientist whose work helps towards beating cancer in the city, will officially open the first Cancer Research UK superstore in Bristol today [Thursday 15 April]. The charity shop, which includes the Coffee Together café at Brislington Retail Park, will be selling everything from furniture to electrical items, clothing and soft furnishings, gifts and women’s, men’s and children�...

Apr 12 2021 Read 15 Times Researchers in the University of Florida’s Department of Chemical Engineering are using Integra’s VOYAGER pipettes to help streamline their workflow and improve pipetting accuracy. Scientists in the Jain lab have developed a CRISPR-based rapid testing kit that can identify biomarkers associated with disease. Long Nguyen, Research Scientist and Lab Manager, explained: “This technology is essentially a nucleic acid biomarker detection system, and has huge scope in ...

Study: One in six men with advanced prostate cancer experiences reduced sense of smell and taste One in six men being treated for advanced prostate cancer experiences a reduced sense of smell and taste, a symptom that could cause increased anxiety among patients because it is also a side effect of COVID-19, according to Tulane researchers. A study published in the journal Supportive Care in Cancer says a reduced sense of smell and taste among some prostate cancer patients is largely associated ...

Copper With just two capsules each day, consumers can make a major difference for their body. Read on below to learn more information about each one of these ingredients. Annona Muricata Annona Muricata, which is more commonly known as soursop or graviola, is used for its leaves, which have many medicinal benefits. For some consumers, it is an alternative option to chemotherapy or radiation when treating cancer. As important as a benefit as this can be, there are many other ways that the ingred...

Henry Ford Cancer Institute launches new initiative to improve minority participation in clinical trials Henry Ford Cancer Institute is launching the Participatory Action for Access to Clinical Trials (PAACT) project to dramatically improve the representation of the African American community and other minorities in cancer clinical trials. Supported by a $750,000 grant from Genentech, PAACT is a community-based research initiative in collaboration with the Detroit Community-Academic Urban Resea...

Novel method can improve the detection of circulating tumor cells Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for more than 80 percent of all lung cancer cases. Despite the aggressive nature of NSCLC, circulating tumor cells that lead to metastases often go undetected in the blood compared to breast, prostate, colorectal, and other cancers. Now, scientists have developed a novel method to better detect the circulating tumor cells (CTCs) that are a te...